IMR Press is a publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a wide readership, IMR Press is dedicated to making positive contributions to academics, libraries as well as to readers and authors. All the editors in IMR Press strive to provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.


Company History

IMR Press is a publisher of open-access peer-reviewed biomedical and life science journals. Our journey began in 2017 when David Zhu, the Founder, CEO, and Chairman, registered IMR Press Limited in Hong Kong and initiated operations. In 2018, we established our first journal, the Journal of Molecular and Clinical Medicine. Responding to growth demands, in November 2019, we registered IMR Press PTE. LTD in Singapore, designating it as the global headquarters of IMR Press. That same year, we established an office in Hangzhou, Zhejiang, China, primarily responsible for technical support such as website hosting and data production, ensuring the continuous provision of high-quality publishing services to the academic community.

From February 2019 to March 2022, to fortify our publishing business and broaden our service portfolio, IMR Press acquired the Clinical and Experimental Obstetrics & Gynecology, Journal of Integrative Neuroscience, and Reviews in Cardiovascular Medicine journals, assuming responsibility for their publication.

In April 2020, IMR Press established the subsidiary MRE Press (https://www.mrepress.net/) in Singapore, responsible for publishing the Journal of Men's Health, Signa Vitae, and European Journal of Gynaecological Oncology journals. Since 2022, due to changes in equity structure, ownership and management of MRE Press have been separated from IMR Press, making it an independently operated company no longer under IMR Press.

In November 2020, IMR Press established the subsidiary Bioscience Research Institute (https://www.fbscience.com/) in Singapore. In October of the same year, IMR Press acquired Frontiers in Bioscience Landmark/Scholar/Elite Editions, which were then published and operated by the Bioscience Research Institute. From January 2022, BRI was merged into IMR Press, and Frontiers in Bioscience Landmark/Scholar/Elite Editions returned to IMR Press.

In August 2023, IMR Press completed the acquisition of FORUM MULTIMEDIA PUBLISHING, becoming the new owner of FORUM MULTIMEDIA PUBLISHING (https://forummmpub.com/). In the same month, IMR Press acquired European Cells & Materials and transferred the publishing rights to FORUM MULTIMEDIA PUBLISHING. Nonetheless, IMR Press and FORUM MULTIMEDIA PUBLISHING continue to operate independently to ensure the continuity of their professionalism and independence.

David Zhu

Founder, Chairman and CEO


Management Team